| 49.41 4.12 (9.1%) | 07-17 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 59.56 |
1-year : | 69.57 |
| Resists | First : | 51 |
Second : | 59.56 |
| Pivot price | 44.17 |
|||
| Supports | First : | 40.32 |
Second : | 33.72 |
| MAs | MA(5) : | 45.12 |
MA(20) : | 43.12 |
| MA(100) : | 39.63 |
MA(250) : | 35.61 |
|
| MACD | MACD : | 1.8 |
Signal : | 1.4 |
| %K %D | K(14,3) : | 71.1 |
D(3) : | 65.2 |
| RSI | RSI(14): 67.9 |
|||
| 52-week | High : | 51 | Low : | 16.37 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ SION ] has closed above the upper band by 24.1%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 19.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 51.08 - 51.28 | 51.28 - 51.49 |
| Low: | 42.68 - 42.87 | 42.87 - 43.06 |
| Close: | 49.07 - 49.43 | 49.43 - 49.8 |
Operating as a biopharmaceutical company, Sionna Therapeutics, Inc. is dedicated to transforming the treatment landscape for individuals with cystic fibrosis. This is achieved by developing innovative medicines designed to restore the normal function of the cystic fibrosis transmembrane conductance regulator.
Fri, 17 Jul 2026
Sionna Therapeutics (SION) Sees 9.2% Surge in Stock Price - GuruFocus
Wed, 15 Jul 2026
Orbimed Advisors LLC Reduces Stake in Sionna Therapeutics Inc - GuruFocus
Sat, 11 Jul 2026
Wedbush initiates coverage of Sionna Therapeutics (SION) with outperform recommendation - MSN
Mon, 06 Jul 2026
Sionna Therapeutics (SION) Jefferies Global Healthcare Conference 2026 Summary - Quartr
Wed, 01 Jul 2026
Price to earnings forward of Sionna Therapeutics, Inc. – NASDAQ:SION - TradingView
Tue, 30 Jun 2026
Sionna Therapeutics: NBD1 Stabilization Could Redefine Cystic Fibrosis Treatment (SION) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 45 (M) |
| Shares Float | 17 (M) |
| Held by Insiders | 6.8 (%) |
| Held by Institutions | 100 (%) |
| Shares Short | 5,520 (K) |
| Shares Short P.Month | 4,640 (K) |
| EPS | -1.87 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.38 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -18.4 % |
| Return on Equity (ttm) | -26.8 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -2.18 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -72 (M) |
| Levered Free Cash Flow | -46 (M) |
| PE Ratio | -26.57 |
| PEG Ratio | 0 |
| Price to Book value | 7.73 |
| Price to Sales | 0 |
| Price to Cash Flow | -31.05 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|